Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind South Africa Анонимен
User created User created Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Анонимен
User created User created Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://korea.progress.im/ko/content/%EC%B9%98%EB%A7%A4%EC%99%80-%EC%BD%94%EB%A1%9C%EB%82%9819-%EC%84%B8%EA%B3%84%EC%A0%81-%EC%9C%A0%ED%96%89%EB%B3%91%EB%93%A4%EC%9D%98-%EA%B2%B0%ED%95%A9 Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Анонимен
User created User created Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Анонимен
User created User created Анонимен
User created User created Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Анонимен
User created User created Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
User created User created Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/covid-19-crise-e-manejo-da-enxaqueca Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind South Africa Анонимен
Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind South Africa Анонимен
User created User created Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Анонимен
User created User created Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://korea.progress.im/ko/content/%EC%B9%98%EB%A7%A4%EC%99%80-%EC%BD%94%EB%A1%9C%EB%82%9819-%EC%84%B8%EA%B3%84%EC%A0%81-%EC%9C%A0%ED%96%89%EB%B3%91%EB%93%A4%EC%9D%98-%EA%B2%B0%ED%95%A9 Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Анонимен
User created User created Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Анонимен
User created User created Анонимен
User created User created Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Анонимен
User created User created Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
User created User created Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/covid-19-crise-e-manejo-da-enxaqueca Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind South Africa Анонимен